Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1

Description:
In Type 1 diabetes mellitus the body does not produce enough insulin, which is required to convert sugar and other food into energy for the body. The disease is typically diagnosed in children and young adults and requires lifelong insulin therapy. This study is looking at administering oral insulin to patients with risk factors for developing diabetes to see if it will prevent or delay the development of the disease.

Medication Under Study:
Oral insulin

Full study title:
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus (TN-07) Protocol TN-07

IRB Study ID:
061103


Who may qualify:

Patients with risks factors for developing type 1 diabetes mellitus

Who does not qualify:

Patients already taking medications that may affect glucose, have certain medical conditions or are not at risk for developing diabetes

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us

    330-543-5012

    E-mail

    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.